These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6713778)

  • 1. Imipramine binding to alpha-1-acid glycoprotein in normal subjects and cardiac patients.
    Freilich DI; Giardina EG
    Clin Pharmacol Ther; 1984 May; 35(5):670-4. PubMed ID: 6713778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methodologic factors influencing plasma binding of alpha-1-acid glycoprotein-bound and albumin-bound drugs.
    Morse DS; Abernethy DR; Greenblatt DJ
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):535-9. PubMed ID: 3934087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma protein binding of drugs after severe burn injury.
    Martyn JA; Abernethy DR; Greenblatt DJ
    Clin Pharmacol Ther; 1984 Apr; 35(4):535-9. PubMed ID: 6705453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for differences in the binding of drugs to the two main genetic variants of human alpha 1-acid glycoprotein.
    Herve F; Gomas E; Duche JC; Tillement JP
    Br J Clin Pharmacol; 1993 Sep; 36(3):241-9. PubMed ID: 9114911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age effects on alpha-1-acid glycoprotein concentration and imipramine plasma protein binding.
    Abernethy DR; Kerzner L
    J Am Geriatr Soc; 1984 Oct; 32(10):705-8. PubMed ID: 6434618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of cancer on the serum protein binding to mianserin and imipramine.
    Torres I; Suárez E; Rodríguez-Sasiain JM; Aguirre C; Calvo R
    Eur J Drug Metab Pharmacokinet; 1995; 20(2):107-11. PubMed ID: 8582434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged variability in plasma protein binding of disopyramide after acute myocardial infarction.
    David BM; Ilett KF; Whitford EG; Stenhouse NS
    Br J Clin Pharmacol; 1983 Apr; 15(4):435-41. PubMed ID: 6849779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. alpha 1-Acid glycoprotein and plasma lidocaine binding.
    Shand DG
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():27-31. PubMed ID: 6705424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between antidepressants and alpha 1-adrenergic receptor antagonists on the binding to alpha 1-acid glycoprotein.
    Ferry DG; Caplan NB; Cubeddu LX
    J Pharm Sci; 1986 Feb; 75(2):146-9. PubMed ID: 2870173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha1-acid glycoprotein concentration and protein binding in trauma.
    Edwards DJ; Lalka D; Cerra F; Slaughter RL
    Clin Pharmacol Ther; 1982 Jan; 31(1):62-7. PubMed ID: 7053306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between alpha 1-acid glycoprotein and lidocaine disposition in myocardial infarction.
    Routledge PA; Shand DG; Barchowsky A; Wagner G; Stargel WW
    Clin Pharmacol Ther; 1981 Aug; 30(2):154-7. PubMed ID: 7249498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of d-methadone, l-methadone, and dl-methadone to proteins in plasma of healthy volunteers: role of the variants of alpha 1-acid glycoprotein.
    Eap CB; Cuendet C; Baumann P
    Clin Pharmacol Ther; 1990 Mar; 47(3):338-46. PubMed ID: 2311335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo protein binding of clindamycin in sera with normal and elevated alpha 1-acid glycoprotein concentrations.
    Kays MB; White RL; Gatti G; Gambertoglio JG
    Pharmacotherapy; 1992; 12(1):50-5. PubMed ID: 1549539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methadone plasma protein binding: alterations in cancer and displacement from alpha 1-acid glycoprotein.
    Abramson FP
    Clin Pharmacol Ther; 1982 Nov; 32(5):652-8. PubMed ID: 7128006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of alfentanil to human alpha 1-acid glycoprotein, albumin and serum.
    Belpaire FM; Bogaert MG
    Int J Clin Pharmacol Ther Toxicol; 1991 Mar; 29(3):96-102. PubMed ID: 2071261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steady-state kinetics of imipramine in transgenic mice with elevated serum AAG levels.
    Holladay JW; Dewey MJ; Yoo SD
    Pharm Res; 1996 Sep; 13(9):1313-6. PubMed ID: 8893267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cancer and its treatments on plasma concentration of alpha 1-acid glycoprotein and propranolol binding.
    Abramson FP; Jenkins J; Ostchega Y
    Clin Pharmacol Ther; 1982 Nov; 32(5):659-63. PubMed ID: 7128007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lidocaine plasma protein binding.
    Routledge PA; Barchowsky A; Bjornsson TD; Kitchell BB; Shand DG
    Clin Pharmacol Ther; 1980 Mar; 27(3):347-51. PubMed ID: 7357791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of disopyramide, methadone, dipyridamole, chlorpromazine, lignocaine and progesterone to the two main genetic variants of human alpha 1-acid glycoprotein: evidence for drug-binding differences between the variants and for the presence of two separate drug-binding sites on alpha 1-acid glycoprotein.
    Hervé F; Duché JC; d'Athis P; Marché C; Barré J; Tillement JP
    Pharmacogenetics; 1996 Oct; 6(5):403-15. PubMed ID: 8946472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered serum protein binding of carbamazepine in disease states associated with an increased alpha 1-acid glycoprotein concentration.
    Baruzzi A; Contin M; Perucca E; Albani F; Riva R
    Eur J Clin Pharmacol; 1986; 31(1):85-9. PubMed ID: 3780833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.